Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral blood.
Lee YK, Lee DW, Kim YL, Lee S, Min CK, Kim YJ, Oh IH, Kim TG, Kim CC, Kim DW. Lee YK, et al. Among authors: kim cc, kim yj, kim yl, kim tg, kim dw. Int J Hematol. 2002 Aug;76(2):180-5. doi: 10.1007/BF02982582. Int J Hematol. 2002. PMID: 12215018
Risk factors for adults with Philadelphia-chromosome-positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real-time quantitative reverse-transcription polymerase chain reaction.
Lee S, Kim DW, Cho B, Kim YJ, Kim YL, Hwang JY, Park YH, Shin HJ, Park CY, Min WS, Kim HK, Kim CC. Lee S, et al. Among authors: kim cc, kim yj, kim dw, kim yl, kim hk. Br J Haematol. 2003 Jan;120(1):145-53. doi: 10.1046/j.1365-2141.2003.03988.x. Br J Haematol. 2003. PMID: 12492591 Free article.
Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
Kim YJ, Kim DW, Lee S, Min CK, Goh HG, Kim SH, Lee JY, Kim YL, Kim HJ, Kim HJ, Lee JW, Kim TG, Min WS, Kim CC. Kim YJ, et al. Among authors: kim cc, kim hj, kim dw, kim yl, kim tg, kim sh. Biol Blood Marrow Transplant. 2004 Oct;10(10):718-25. doi: 10.1016/j.bbmt.2004.06.033. Biol Blood Marrow Transplant. 2004. PMID: 15389438 Free article. Clinical Trial.
The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S, Kim YJ, Min CK, Kim HJ, Eom KS, Kim DW, Lee JW, Min WS, Kim CC. Lee S, et al. Among authors: kim cc, kim yj, kim hj, kim dw. Blood. 2005 May 1;105(9):3449-57. doi: 10.1182/blood-2004-09-3785. Epub 2005 Jan 18. Blood. 2005. PMID: 15657178 Free article. Clinical Trial.
Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or older.
Eom KS, Kim HJ, Min WS, Lee S, Min CK, Cho BS, Kim SY, Kim YJ, Lee DG, Choi SM, Cho SG, Kim DW, Lee JW, Shin WS, Kim CC. Eom KS, et al. Among authors: kim cc, kim yj, kim hj, kim dw, kim sy. Eur J Haematol. 2007 Nov;79(5):398-404. doi: 10.1111/j.1600-0609.2007.00946.x. Epub 2007 Oct 4. Eur J Haematol. 2007. PMID: 17916082 Clinical Trial.
The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S, Kim YJ, Chung NG, Lim J, Lee DG, Kim HJ, Min CK, Lee JW, Min WS, Kim CC. Lee S, et al. Among authors: kim cc, kim yj, kim hj. Cancer. 2009 Feb 1;115(3):561-70. doi: 10.1002/cncr.24026. Cancer. 2009. PMID: 19117346 Free article. Clinical Trial.
324 results